| Product No | EMEA/H/C/002387 |
|---|---|
| Brand Name | Zyclara |
| Nonproprietary Name | imiquimod |
| API | imiquimod |
| ATC Code | D06BB10 |
| Indications | Zyclara is indicated for the topical treatment of clinically typical, non-hyperkeratotic, non-hypertrophic, visible or palpable actinic keratosis of the full face or balding scalp in immunocompetent adults when other topical treatment options are contraindicated or less appropriate. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Viatris Healthcare Limited |
| Status | Authorised(授权) |
| Authorization Date | 2012-08-23 |
| Version | 14 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information